X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
breast cancer (5) 5
genetic aspects (5) 5
mutation (5) 5
ovarian cancer (5) 5
gene mutations (4) 4
index medicus (4) 4
oncology (4) 4
brca1 protein (3) 3
cancer (3) 3
genes (3) 3
germline mutations (3) 3
analysis (2) 2
chemotherapy (2) 2
clonal hematopoiesis (2) 2
genetic variation (2) 2
humans (2) 2
p53 protein (2) 2
physiological aspects (2) 2
ppm1d (2) 2
proteins (2) 2
research (2) 2
research article (2) 2
tp53 (2) 2
tumor proteins (2) 2
women (2) 2
adult (1) 1
age (1) 1
aged (1) 1
alpha-hemolysin (1) 1
animals (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - toxicity (1) 1
antitumor-activity (1) 1
apoptosis (1) 1
apoptosis - drug effects (1) 1
apoptosis regulatory proteins - metabolism (1) 1
ataxia-telangiectasia (1) 1
bacillus-subtilis (1) 1
bacterial genetics (1) 1
bard1 (1) 1
blood (1) 1
brca1 (1) 1
breast cancer predisposition (1) 1
breast neoplasms - genetics (1) 1
breast neoplasms - pathology (1) 1
brip1 gene (1) 1
cancer biology (1) 1
cancers (1) 1
carcinoma (1) 1
carriers (1) 1
cell line, tumor (1) 1
cell survival - drug effects (1) 1
cell viability (1) 1
cell walls (1) 1
cells (1) 1
chaperones (1) 1
chek2-asterisk-1100delc (1) 1
confer susceptibility (1) 1
consortia (1) 1
deoxyribonucleic acid--dna (1) 1
diagnosis (1) 1
dose-response relationship, drug (1) 1
drug and narcotic control (1) 1
drug safety (1) 1
drugs, generic - administration & dosage (1) 1
drugs, generic - toxicity (1) 1
e-cadherin (1) 1
early onset breast cancer (1) 1
epidermal growth factor (1) 1
erbb-2 protein (1) 1
estrogen receptors (1) 1
expression (1) 1
families (1) 1
fanconi anemia complementation group proteins - genetics (1) 1
female (1) 1
fitness (1) 1
founder mutation (1) 1
framework (1) 1
gene (1) 1
generic drugs (1) 1
genetic association studies (1) 1
genetic predisposition to disease (1) 1
genetics & heredity (1) 1
genome sequence (1) 1
genome, bacterial (1) 1
genomes (1) 1
genomics (1) 1
germ-line mutation (1) 1
growth-factor (1) 1
health aspects (1) 1
health risks (1) 1
hemopoiesis (1) 1
hereditary breast cancer (1) 1
imatinib (1) 1
imatinib mesylate - administration & dosage (1) 1
imatinib mesylate - toxicity (1) 1
imatinib narrow therapeutic index drug (1) 1
indoles - administration & dosage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Human Mutation, ISSN 1059-7794, 12/2018, Volume 39, Issue 12, pp. 2040 - 2046
The Li‐Fraumeni cancer predisposition syndrome (LFS1) presents with a variety of tumor types and the TP53 gene is covered by most diagnostic cancer gene... 
clonal hematopoiesis | PPM1D | Li‐Fraumeni syndrome | chemotherapy | TP53 | Chemotherapy | Genetic aspects | Diagnosis | Gene mutations | Tumor proteins | Cancer | Mutation | p53 Protein | Deoxyribonucleic acid--DNA | Ovarian cancer | Hemopoiesis
Journal Article
Breast Cancer Research, ISSN 1465-5411, 01/2018, Volume 20, Issue 1, pp. 7 - 6
Journal Article
BREAST CANCER RESEARCH, ISSN 1465-542X, 04/2019, Volume 21, Issue 1, p. 55
BackgroundThe role of the BARD1 gene in breast cancer (BC) and ovarian cancer (OC) predisposition remains elusive, as published case-control investigations... 
BARD1 | PROTEIN | ONCOLOGY | Germline mutations | Early onset breast cancer | MUTATIONS | BRCA1 | Ovarian cancer | Genetic aspects | Breast cancer | Research | Gene mutations | Genetic variation
Journal Article
Cancer Medicine, ISSN 2045-7634, 04/2018, Volume 7, Issue 4, pp. 1349 - 1358
The prevalence of germ line mutations in non‐BRCA1/2 genes associated with hereditary breast cancer (BC) is low, and the role of some of these genes in BC... 
hereditary breast cancer | Breast cancer predisposition | RISK | CARRIERS | CHEK2-ASTERISK-1100DELC | WOMEN | RAD51C | ONCOLOGY | FOUNDER MUTATION | FAMILIES | GERMLINE MUTATIONS | CONFER SUSCEPTIBILITY | ATAXIA-TELANGIECTASIA | Gene mutations | Genes | Medical tests | Genetic aspects | Breast cancer | Tumor proteins | Cancer | Ovarian cancer
Journal Article
Human Mutation, ISSN 1059-7794, 12/2018, Volume 39, Issue 12, pp. 2040 - 2046
The Li-Fraumeni cancer predisposition syndrome (LFS1) presents with a variety of tumor types and the TP53 gene is covered by most diagnostic cancer gene... 
clonal hematopoiesis | PPM1D | chemotherapy | TP53 | Li-Fraumeni syndrome | CANCERS | GENETICS & HEREDITY | FRAMEWORK | BLOOD
Journal Article
Regulatory Toxicology and Pharmacology, ISSN 0273-2300, 06/2016, Volume 77, pp. 25 - 34
Narrow Therapeutic Index Drugs (NTIDs) are characterized by a small range between therapeutic and toxicological effect. Missing international harmonized... 
Imatinib | Sunitinib | Receptor tyrosine kinase (RTK) | Toxicity | Cell viability | Tyrosine kinase inhibitor (TKI) | Drug safety | Apoptosis | Narrow Therapeutic Index Drug (NTID) | Narrow therapeutic index drug (NTID) | SURVIVAL | MANAGEMENT | VIVO | MEDICINE, LEGAL | PHOSPHORYLATION | SAFETY | Imatinib Narrow Therapeutic Index Drug (NTID) | ANTITUMOR-ACTIVITY | SU11248 | TYROSINE KINASE INHIBITOR | PHARMACOLOGY & PHARMACY | TOXICOLOGY | GROWTH-FACTOR | CARCINOMA | Phosphorylation | Apoptosis - drug effects | Humans | Antineoplastic Agents - administration & dosage | Indoles - administration & dosage | Antineoplastic Agents - toxicity | Dose-Response Relationship, Drug | Pyrroles - administration & dosage | Imatinib Mesylate - administration & dosage | Inhibitory Concentration 50 | Toxicity Tests - methods | Drug and Narcotic Control | Cell Survival - drug effects | Risk Assessment | Drugs, Generic - administration & dosage | Neoplasms - enzymology | Imatinib Mesylate - toxicity | Indoles - toxicity | Organ Specificity | Apoptosis Regulatory Proteins - metabolism | Neoplasms - drug therapy | Protein Kinase Inhibitors - administration & dosage | Animals | Signal Transduction - drug effects | Pyrroles - toxicity | Cell Line, Tumor | Protein Kinase Inhibitors - toxicity | Neoplasms - pathology | Drugs, Generic - toxicity | Proteins | Antimitotic agents | Tyrosine | Antineoplastic agents | Health aspects | Analysis | Generic drugs | Index Medicus
Journal Article
International Journal of Medical Microbiology, ISSN 1438-4221, 2012, Volume 302, Issue 2, pp. 84 - 87
Journal Article
Journal Article
Pharmazeutische Zeitung, ISSN 0031-7136, 2014, Volume 159, Issue 48
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.